News
Eli Lilly (NYSE:LLY) has been in the spotlight recently with a 3.96% share price increase over the past month. The selection ...
Zacks Investment Research on MSN17h
What is the Intent Behind Eli Lilly's Recent M&A Deals Spree?Eli Lilly LLY signed a definitive agreement to acquire Verve Therapeutics VERV for a total deal value of nearly $1.3 billion.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback